KODAK AMERLITE CK-MB CONTROL SERA LAN.4413— 510(k) K925880

Name: FDA 510(k) clearance K925880
Creator: U.S. Food and Drug Administration
Published: 1993-02-05

Substantially Equivalent

Eastman Kodak Company

FDA 510(k) clearance K925880 for KODAK AMERLITE CK-MB CONTROL SERA LAN.4413, Substantially Equivalent on 1993-02-05. Applicant: Eastman Kodak Company. Device class: 1.

Clearance details

Applicant: Eastman Kodak Company
Product code: Code JJX
Device class: Class 1
Regulation: 21 CFR 862.1660
Advisory panel: Clinical Chemistry
Date received: 1992-11-19
Decision date: 1993-02-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Rochester, NY, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JJX

view all

K170678 — Beta-CrossLaps CalCheck 52017-04-04
K162173 — Elecsys CYFRA 21-1 CalCheck 52017-01-12
K162514 — Multichem A1c2016-10-26
K161874 — Audit MicroControls Linearity DROP LQ Blood Glucose2016-08-10
K161522 — LIAISON EBV IgM Serum Control Set2016-06-30

More clearances from Eastman Kodak Company

view all

K060550 — KODAK DIRECTVIEW DR 3000 SYSTEM 64KW/80KW GENERATORS, MODELS 6551345, 65513862006-03-31
K060137 — KODAK ECLIPSE IMAGE PROCESSING SOFTWARE2006-03-16
K060079 — KODAK MODEL CR-7400 DIGITAL RADIOGRAPHY SYSTEM2006-02-08
K060055 — KODAK PACS2006-02-07
K053347 — KODAK CARESTREAM PACS2006-01-04

Adverse events under product code JJX

product code JJX

Other: 2
Total: 2

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.